Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LINDE PLCLIN · Entity 2835 | Executive Vice President | June 03, 2020 | June 04, 2020 |
| ROGERS CORPROG · Entity 4438 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LINDE PLC
Report date June 03, 2020 · Filed June 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 31,292.522 |
Ending reported balance
After 2020-06-03 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2020-06-03 · Exercise / conversion · Acquired 9,405 · Balance 40,697.522 Row 2 · 2020-06-03 · Tax withholding · Disposed 6,792 · Balance 33,905.522 F1: Shares withheld from option exercise to pay exercise price and taxes. No market sale of shares occurred. Row 3 · 2020-06-03 · Exercise / conversion · Acquired 15,790 · Balance 49,695.522 Row 4 · 2020-06-03 · Tax withholding · Disposed 11,732 · Balance 37,963.522 F1: Shares withheld from option exercise to pay exercise price and taxes. No market sale of shares occurred. Row 5 · 2020-06-03 · Sale · Disposed 6,671 · Balance 31,292.522 F2: The price reported is the weighted average sale price. The sale prices ranged from $211.73 to $212.14. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.58 · Expires 2023-02-26 | Direct | 0 |
Reported balance
After 2020-06-03 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-06-03 · Exercise / conversion · Disposed 15,790 · Balance 0 F8: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $102.22 · Expires 2026-02-23 | Direct | 40,000 |
Reported balance
After 2020-06-03 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2020-06-03 · Exercise / conversion · Disposed 9,405 · Balance 40,000 F9: This option vests over three years in three consecutive equal annual installments beginning on February 23, 2017. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09 | Direct | 23,545 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 23,545 F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $176.63 · Expires 2029-03-20 | Direct | 26,230 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 26,230 F7: This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.80 · Expires 2024-02-25 | Direct | 19,900 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 19,900 F8: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.38 · Expires 2025-02-24 | Direct | 26,490 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 26,490 F8: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28 | Direct | 39,585 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 39,585 F10: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27 | Direct | 32,335 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 32,335 F11: Conversion to Linde plc ordinary shares is on a one-for-one basis. |
| Ordinary SharesSEC Table I · non-derivative | Indirect401(k) | 1,709.075 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 1,709.075 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,935 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 1,935 F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,330 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 2,330 F4: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one-basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 3,885 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 3,885 F5: Restricted Stock units that will vest in full and payout on or about February 23, 2021 in Linde plc Ordinary Shares on a one-for-one basis. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 120.569 |
Reported balance
Holding disclosure · report date 2020-06-03 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 120.569 F11: Conversion to Linde plc ordinary shares is on a one-for-one basis. F12: Deferred stock units acquired under the Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for one basis in accordance with the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld from option exercise to pay exercise price and taxes. No market sale of shares occurred.
F2: The price reported is the weighted average sale price. The sale prices ranged from $211.73 to $212.14. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.
F4: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one-basis.
F5: Restricted Stock units that will vest in full and payout on or about February 23, 2021 in Linde plc Ordinary Shares on a one-for-one basis.
F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
F7: This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.
F8: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
F9: This option vests over three years in three consecutive equal annual installments beginning on February 23, 2017.
F10: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.
F11: Conversion to Linde plc ordinary shares is on a one-for-one basis.
F12: Deferred stock units acquired under the Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for one basis in accordance with the Plan.
ROGERS CORP
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital (Common) StockSEC Table I · non-derivative | Direct | 6,837 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 1,427 · Balance 6,837 F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 6, 2026, award of deferred stock units. |
| Capital (Common) StockSEC Table I · non-derivative | IndirectSpousal Access Trust | 615 |
Reported balance
Holding disclosure · report date 2026-05-06 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 615 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 6, 2026, award of deferred stock units.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CMC Materials, Inc.
Report date July 06, 2022 · Filed July 07, 2022
Section 16 reporting ended · disclosed 2022-07-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 1
1 source rowRow 1 · 2022-07-06 · Disposition to issuer · Disposed 1,897 · Balance 0 F1: Disposed of in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), by and among the Issuer, Entegris, Inc. ("Entegris") and Yosemite Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of Entegris, pursuant to which the Issuer was merged with and into Merger Sub, with the Issuer surviving as a wholly owned subsidiary of Entegris (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Issuer common stock was cancelled and converted into (i) $133.00 in cash and (ii) 0.4506 of a share of Entegris common stock, with cash in lieu of any fractional shares of Entegris common stock (together, the "Merger Consideration"). The Merger closed on July 6, 2022. On July 5, 2022, the closing price of the Issuer was $173.69, and the closing price of Entegris was $90.75. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Issuer common stock. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2031-06-01 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-07-06 · Disposition to issuer · Disposed 1,107 · Balance 0 F2: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F3: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 6/1/2022, vested in full and was assumed and converted into an Entegris Option to purchase 2,015 shares of Entegris common stock an exercise price of $84.59 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), by and among the Issuer, Entegris, Inc. ("Entegris") and Yosemite Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of Entegris, pursuant to which the Issuer was merged with and into Merger Sub, with the Issuer surviving as a wholly owned subsidiary of Entegris (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Issuer common stock was cancelled and converted into (i) $133.00 in cash and (ii) 0.4506 of a share of Entegris common stock, with cash in lieu of any fractional shares of Entegris common stock (together, the "Merger Consideration"). The Merger closed on July 6, 2022. On July 5, 2022, the closing price of the Issuer was $173.69, and the closing price of Entegris was $90.75. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Issuer common stock.
F2: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement).
F3: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 6/1/2022, vested in full and was assumed and converted into an Entegris Option to purchase 2,015 shares of Entegris common stock an exercise price of $84.59 per share.
PRAXAIR INC
Report date October 31, 2018 · Filed November 01, 2018
Section 16 reporting ended · disclosed 2018-11-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirect401(k) | 0 |
Reported balance
After 2018-10-31 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-10-31 · Disposition to issuer · Disposed 1,328.5434 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 2
1 source rowRow 2 · 2018-10-31 · Disposition to issuer · Disposed 26,747.951 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-10-31 · Disposition to issuer · Disposed 3,885 · Balance 0 F2: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-10-31 · Disposition to issuer · Disposed 3,510 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-10-31 · Disposition to issuer · Disposed 4,328 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-10-31 · Disposition to issuer · Disposed 3,588 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-10-31 · Disposition to issuer · Disposed 2,960 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2021-02-22 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-10-31 · Disposition to issuer · Disposed 13,195 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $109.68 · Expires 2022-02-28 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-10-31 · Disposition to issuer · Disposed 18,430 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.58 · Expires 2023-02-26 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-10-31 · Disposition to issuer · Disposed 15,790 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.80 · Expires 2024-02-25 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-10-31 · Disposition to issuer · Disposed 19,900 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.38 · Expires 2025-02-24 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-10-31 · Disposition to issuer · Disposed 26,490 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $102.22 · Expires 2026-02-23 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2018-10-31 · Disposition to issuer · Disposed 49,405 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2018-10-31 · Disposition to issuer · Disposed 39,585 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2018-10-31 · Disposition to issuer · Disposed 32,335 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
F2: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2019 Filed Feb 27, 2019 23:19 UTC | LINDE PLC LIN · Entity 2835 | Exercise / conversionOrdinary Shares | 3,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001707925-19-000005 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,502.522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 20:29 UTC | LINDE PLC LIN · Entity 2835 | Tax withholdingOrdinary Shares | 1,755.429 | $165.47 | $290,470.84 |
DisclosureSEC source: 0001707925-18-000034 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,992.522 F1 · shares: Ordinary Shares withheld for the payment of taxes in connection with the payout in Ordinary Shares of previously granted deferred stock units. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerStock Option (right to buy) · Derivative | 32,335 | Not disclosed Strike: $154.00 | Not disclosed |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 15 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,335 shares Expires 2028-02-27 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F8 · price: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F8 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerStock Option (right to buy) · Derivative | 39,585 | Not disclosed Strike: $118.71 | Not disclosed |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 14 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,585 shares Expires 2027-02-28 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F7 · price: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F7 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerStock Option (right to buy) · Derivative | 49,405 | Not disclosed Strike: $102.22 | Not disclosed |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 13 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,405 shares Expires 2026-02-23 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F6 · price: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F6 · derivative.exercise_date: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerStock Option (right to buy) · Derivative | 26,490 | Not disclosed Strike: $128.38 | Not disclosed |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 12 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,490 shares Expires 2025-02-24 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerStock Option (right to buy) · Derivative | 19,900 | Not disclosed Strike: $128.80 | Not disclosed |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 11 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,900 shares Expires 2024-02-25 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerStock Option (right to buy) · Derivative | 15,790 | Not disclosed Strike: $110.58 | Not disclosed |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 10 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,790 shares Expires 2023-02-26 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerStock Option (right to buy) · Derivative | 18,430 | Not disclosed Strike: $109.68 | Not disclosed |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 9 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,430 shares Expires 2022-02-28 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerStock Option (right to buy) · Derivative | 13,195 | Not disclosed Strike: $97.84 | Not disclosed |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 8 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,195 shares Expires 2021-02-22 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerRestricted Stock Units · Derivative | 2,960 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 7 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,960 shares Expires not disclosed F4 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F4 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F4 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerRestricted Stock Units · Derivative | 3,588 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 6 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,588 shares Expires not disclosed F3 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F3 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F3 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerRestricted Stock Units · Derivative | 4,328 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 5 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,328 shares Expires not disclosed F4 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F4 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F4 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerRestricted Stock Units · Derivative | 3,510 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 4 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,510 shares Expires not disclosed F3 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F3 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F3 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerRestricted Stock Units · Derivative | 3,885 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · derivative · entry 3 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,885 shares Expires not disclosed F2 · derivative.exercise_price: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F2 · derivative.exercise_date: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerCommon Stock | 26,747.951 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F1 · price: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:09 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerCommon Stock | 1,328.5434 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000077 · edgar.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Disclosed balance after: 0 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F1 · price: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:20 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock · Derivative | 52.695 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000017 · edgar.xml · derivative · entry 15 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,313.513 Underlying: Common Stock · 52.695 shares Expires not disclosed F9 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F10 · derivative.exercise_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. F10 · derivative.expiration_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:20 UTC | PRAXAIR INC PX · Entity 162268 | GrantStock Option (right to buy) · Derivative | 32,335 | $0.00 Strike: $154.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000017 · edgar.xml · derivative · entry 7 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,335 Underlying: Common Stock · 32,335 shares Expires 2028-02-27 F5 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:20 UTC | PRAXAIR INC PX · Entity 162268 | GrantCommon Stock | 3,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000017 · edgar.xml · nonDerivative · entry 4 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,251 F3 · shares: Restricted stock unit award granted on February 27, 2018, payable in shares of Praxair Common Stock, vesting 100% on February 27, 2021. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:20 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionPerformance Share Units · Derivative | 1,494 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000884905-18-000017 · edgar.xml · derivative · entry 6 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,494 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The PSU paid out on February 26, 2018 and the number of shaes awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_price: The PSU paid out on February 26, 2018 and the number of shaes awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · price: The PSU paid out on February 26, 2018 and the number of shaes awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_date: The PSU paid out on February 26, 2018 and the number of shaes awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.expiration_date: The PSU paid out on February 26, 2018 and the number of shaes awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:20 UTC | PRAXAIR INC PX · Entity 162268 | GrantPerformance Share Units · Derivative | 1,494 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000017 · edgar.xml · derivative · entry 5 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,494 Underlying: Common Stock · 1,494 shares Expires not disclosed F4 · derivative.exercise_price: The PSU paid out on February 26, 2018 and the number of shaes awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · price: The PSU paid out on February 26, 2018 and the number of shaes awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_date: The PSU paid out on February 26, 2018 and the number of shaes awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.expiration_date: The PSU paid out on February 26, 2018 and the number of shaes awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:20 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 693 | $155.62 | $107,844.66 |
DisclosureSEC source: 0000884905-18-000017 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,366 F2 · shares: Shares of common stock withheld from the PSU payout to cover tax withholdings. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:20 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 1,494 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000017 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 24, 2015 (the "PSU"). Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 13:21 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionStock Option (right to buy) · Derivative | 10,230 | $0.00 Strike: $76.16 | $0.00 |
DisclosureSEC source: 0000884905-18-000005 · edgar.xml · derivative · entry 4 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,230 shares Expires 2020-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 13:21 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 6,635 | $165.52 | $1,098,225.20 |
DisclosureSEC source: 0000884905-18-000005 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,565 F1 · shares: Shares of common stock withheld to pay the option exercise price, taxes and fees. No market sale of shares occurred. The reporting person acquired and held 3,595 shares net of the shares withheld. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 13:21 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 10,230 | $76.16 | $779,116.80 |
DisclosureSEC source: 0000884905-18-000005 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 13:39 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock · Derivative | 65.718 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000019 · edgar.xml · derivative · entry 3 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,161.692 Underlying: Common Stock · 65.718 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. F2 · derivative.expiration_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:02 UTC | PRAXAIR INC PX · Entity 162268 | GrantStock Option (right to buy) · Derivative | 39,585 | $0.00 Strike: $118.71 | $0.00 |
DisclosureSEC source: 0000884905-17-000010 · edgar.xml · derivative · entry 6 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,585 Underlying: Common Stock · 39,585 shares Expires 2027-02-28 F4 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. F4 · derivative.expiration_date: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:02 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionPerformance Share Units · Derivative | 1,278 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000884905-17-000010 · edgar.xml · derivative · entry 5 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,278 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 25, 2014 (the "PSU"). F3 · price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.expiration_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F1 · derivative.underlying_shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 25, 2014 (the "PSU"). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:02 UTC | PRAXAIR INC PX · Entity 162268 | GrantPerformance Share Units · Derivative | 1,278 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000010 · edgar.xml · derivative · entry 4 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,278 Underlying: Common Stock · 1,278 shares Expires not disclosed F3 · security: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.expiration_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:02 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 439 | $118.11 | $51,850.29 |
DisclosureSEC source: 0000884905-17-000010 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,970 F2 · shares: Shares of common stock withheld from the PSU payout to cover tax withholdings. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:02 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 1,278 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000010 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 25, 2014 (the "PSU"). Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 12:09 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $83.89 | $0.00 |
DisclosureSEC source: 0000884905-16-000180 · edgar.xml · derivative · entry 9 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2018-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 12:09 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionStock Option (right to buy) · Derivative | 2,897 | $0.00 Strike: $83.89 | $0.00 |
DisclosureSEC source: 0000884905-16-000180 · edgar.xml · derivative · entry 8 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,897 shares Expires 2018-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 12:09 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionStock Option (right to buy) · Derivative | 5,103 | $0.00 Strike: $83.89 | $0.00 |
DisclosureSEC source: 0000884905-16-000180 · edgar.xml · derivative · entry 7 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,897 Underlying: Common Stock · 5,103 shares Expires 2018-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 12:09 UTC | PRAXAIR INC PX · Entity 162268 | SaleCommon Stock | 12,000 | $117.41 | $1,408,920.00 |
DisclosureSEC source: 0000884905-16-000180 · edgar.xml · nonDerivative · entry 6 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,131 F2 · price: The $117.41 price reported is the weighted average sale price. The sale prices ranged from $117.30 to $117.60 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 12:09 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 12,000 | $83.89 | $1,006,680.00 |
DisclosureSEC source: 0000884905-16-000180 · edgar.xml · nonDerivative · entry 5 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 12:09 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 2,897 | $83.89 | $243,029.33 |
DisclosureSEC source: 0000884905-16-000180 · edgar.xml · nonDerivative · entry 4 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 12:09 UTC | PRAXAIR INC PX · Entity 162268 | SaleCommon Stock | 5,103 | $117.37 | $598,939.11 |
DisclosureSEC source: 0000884905-16-000180 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,234 F1 · price: The $117.37 price reported is the weighted average sale price. The sale prices ranged from $117.30 to $117.415 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 12:09 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 5,103 | $83.89 | $428,090.67 |
DisclosureSEC source: 0000884905-16-000180 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,337 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.